← All trials
NCT01921972
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2004
- Primary completion
- Nov 1, 2008
- Completion date
- May 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 232
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Humboldt UniversityLead sponsor
- University of BonnOverall official - principal investigator
- University of HamburgOverall official - principal investigator
- University of HeidelbergOverall official - principal investigator
- University of GoettingenOverall official - principal investigator
- University of FreiburgOverall official - principal investigator
- J. W. Goethe UniversityOverall official - principal investigator
- Free University of BerlinStudy director
- German Federal Ministry of Education and ResearchCollaborator
- University of DuesseldorfOverall official - principal investigator
- Technical University of MunichOverall official - principal investigator
- University of Erlangen-NurembergOverall official - principal investigator
- University of HeidelbergStudy director
- Humboldt UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.